UNSPSC 51151631: Dexetimide

This classification denotes an antimuscarinic agent with the molecular formula C23H26N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 43477QYX3D, chemically known as (rs)-3-(1-benzyl-4-piperidyl)-3-phenyl-2,6-piperidindion but generally known as dexetimide, which bears US NIH Compound Identifier 21847. European Medicines Agency schedules Dexetimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07026MIG.

UNSPSC 51151631 Dexetimide is a Commodity code that, based on recent state and local solicitations, does not align with the work being procured under this code designation. The most recent opportunities posted under this code are for naloxone and drug deactivation systems (Seminole County, Florida) and pharmaceutical direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), neither of which corresponds to dexetimide, an anticholinergic medication used to treat motion sickness and vestibular disorders. The code shows little relevant recent activity in state and local procurement tied to its nominal scope. The Seminole County solicitation (IFB 60459723LAS, due July 26, 2023) procured 1,900 units of naloxone annually through competitive sealed bidding, while the Texas HHS RFI (HHS0017013, posted April 3, 2026) sought vendor information on direct-to-manufacturer pharmacy programs — both are distinct from dexetimide procurement and suggest the code may be incorrectly tagged or inactive for its intended pharmaceutical commodity.

The geographic activity visible under this code spans Florida and Texas, but the mismatch between the code's nominal scope and the actual solicitations posted makes the geographic and issuing-body characterization unreliable for business development purposes. Seminole County represented a recurring county-level health procurer, while Texas HHS demonstrated state-level pharmacy program interest, but neither transaction is representative of dexetimide purchasing patterns. Practitioners should verify the correct UNSPSC code for dexetimide-specific opportunities or flag this code for administrative review to ensure proper taxonomy alignment in future procurement notices.